These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5719637)

  • 1. [Prolonged-action tablets with plastic matrix].
    Blanch J; García F; Arancibia A
    Farmaco Prat; 1968 Apr; 23(4):182-94. PubMed ID: 5719637
    [No Abstract]   [Full Text] [Related]  

  • 2. Tablets of 7-(3'-(methylhydroxylethylamino)-2'-hydroxypropyl)-theophylline nicotinate with prolonged action. II. Retardation of the drug release by polymer coating of tablets.
    Chodkowska-Granicka B; Pawlak Z; Pawlak E; Surowiecki J
    Acta Pol Pharm; 1972; 29(6):618-22. PubMed ID: 4670139
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hydrophilic gel matrix tablets for oral administration of drugs].
    Rabisková M; Vostalová L; Medvecká G; Horácková D
    Ceska Slov Farm; 2003 Sep; 52(5):211-7. PubMed ID: 14619697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural polymers in the formulation of hydrophilic matrix tablets].
    Sedláková M; Rabisková M; Spilková J
    Ceska Slov Farm; 2006 Jan; 55(1):4-11. PubMed ID: 16502804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of peroral delayed-action drug forms using biological polymers as the base. 4. Preparation of erosion tablets with a base of starch hydrolysis products].
    Mank R; Kala H; Lorenz A
    Pharmazie; 1989 Sep; 44(9):617-8. PubMed ID: 2608707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unified mathematical model for diffusion from drug-polymer composite tablets.
    Fu JC; Hagemeir C; Moyer DL
    J Biomed Mater Res; 1976 Sep; 10(5):743-58. PubMed ID: 977604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obtaining of prolonged action of drugs based on insoluble matrix].
    Chodkowska-Granicka B; Michalski K; Surowiecki J; Pawlak E; Trojanowska Z
    Acta Pol Pharm; 1970; 27(3):285-90. PubMed ID: 5456904
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors affecting the formulation of sustained release potassium chloride tablets.
    Senel S; Capan Y; Hincal AA
    Pharmazie; 1991 Nov; 46(11):792-5. PubMed ID: 1811230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
    Fayed MH; Mahrous GM; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(5):971-81. PubMed ID: 21639691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of sustained release calcium alginate beads and matrix tablets of acetazolamide.
    Barzegar-Jalali M; Hanaee J; Omidi Y; Ghanbarzadeh S; Ziaee S; Bairami-Atashgah R; Adibkia K
    Drug Res (Stuttg); 2013 Feb; 63(2):60-4. PubMed ID: 23447074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strength of the insoluble residues of plastic matrix slow release tablets (Duretter) in vitro and in vivo.
    Dahlinder LE; Graffner C; Sjögren J
    Acta Pharm Suec; 1973 Sep; 10(4):323-32. PubMed ID: 4759357
    [No Abstract]   [Full Text] [Related]  

  • 17. Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology.
    Shah SN; Asghar S; Choudhry MA; Akash MS; ur Rehman N; Baksh S
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1470-8. PubMed ID: 19929206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of liquid capillary penetration into inert polymer matrices.
    Carli F; Simioni L
    Pharm Acta Helv; 1978; 53(11):320-6. PubMed ID: 746041
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and evaluation of 1- and 3-layer matrices of verapamil hydrochloride for sustaining its release.
    Siahi MR; Barzegar-Jalali M; Monajjemzadeh F; Ghaffari F; Azarmi S
    AAPS PharmSciTech; 2005 Dec; 6(4):E626-32. PubMed ID: 16408864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peroral drugs with prolonged action. I. Tablets with soluble drug incorporated into stearic acid].
    Chalabala M; Starha L
    Cesk Farm; 1968 Jul; 17(6):290-2. PubMed ID: 5699394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.